Friday, May 23, 2008 9:45:11 PM
April 28, 4:05 pm ET
EDEN PRAIRIE, Minn., April 28, 2008 (PRIME NEWSWIRE) -- NVE Corporation (NasdaqCM:NVEC - News) announced that it plans to release its financial results for the quarter and fiscal year ended March 31, 2008 on Wednesday, May 7, 2008 after the close of the Nasdaq Regular Market. The company will hold its quarterly conference call later that day at 4:00 p.m. Central Time.
The quarterly call will be broadcast live over the Internet and can be accessed through the Investor Events section of NVE's Website (http://www.nve.com). An archive of the call will also be available.
Parties who wish to participate in the call are requested to contact NVE Investor Relations at 952-829-9217 no later than May 5, 2008 to reserve a position for the call and to receive the conference telephone number.
NVE is a leader in the practical commercialization of spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store and transmit information. The company manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. NVE has also licensed its spintronic magnetoresistive random access memory technology, commonly known as MRAM.
Statements we use that relate to future plans, events, financial results or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K and other reports filed with the SEC.
Contact:
NVE Corporation
Curt A. Reynders, Chief Financial Officer
(952) 829-9217
Source: Shareholder.com; NVE Corporation
Recent NVEC News
- NVE Schedules Conference Call on Fourth-Quarter and Fiscal Year Results • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:05:16 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 04:26:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:24:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 10:20:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/24/2024 03:17:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/17/2024 09:11:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:08:54 PM
- NVE Schedules Conference Call on Third-Quarter Results • GlobeNewswire Inc. • 01/10/2024 09:05:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/03/2024 09:05:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/18/2023 08:10:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 08:05:37 PM
- NVE Schedules Conference Call on Second-Quarter Results • GlobeNewswire Inc. • 10/11/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 09:17:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 09:05:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 08:57:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 08:50:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 08:45:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/19/2023 08:10:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 08:02:49 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/19/2023 08:02:18 PM
- NVE Schedules Conference Call on First-Quarter Results • GlobeNewswire Inc. • 07/12/2023 08:05:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM